Pierluigi Porcu
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL) (NCT06789159) | Pierluigi Porcu | 2026-08-01 |
Track Pierluigi Porcu automatically
Every clearance here is in the API, with alerts when new ones post.